文献速递血栓与止血

哥本哈根奠基者变异GP1BA c.58T>G是丹麦遗传性血小板减少症最常见病因

The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.
PubMed 文献 · J Thromb Haemost · 2021-08-11

该研究对106例疑似遗传性血小板减少症患者进行全外显子或全基因组测序,诊断14例(13%)为单等位基因Bernard-Soulier综合征(mBSS)。6个无关先证者携带GP1BA c.58T>G(p.Cys20Gly)变异并共享2.0 Mb染色体17区域,证实为奠基者变异。mBSS患者与野生型家庭成员间TPO水平无差异(P > .05)。

要点

  • 丹麦遗传性血小板减少症中最常见形式为mBSS,由GP1BA c.58T>G奠基者变异引起。
  • 疑似IT患者中mBSS检出率为13%(14/106)。
  • mBSS患者与野生型家庭成员TPO水平无显著差异(P > .05)。

核心结论

  • 丹麦最常见的遗传性血小板减少症形式为mBSS,由哥本哈根奠基者变异GP1BA c.58T>G引起。

研究设计与样本

  • 对106例疑似遗传性血小板减少症患者进行全外显子或全基因组测序,并对mBSS家系进行共分离分析。
  • 所有先证者及家庭成员进行表型特征分析,通过确认先证者无亲缘关系且变异周围区域共享来进行奠基者突变分析。
  • 采用固相三明治ELISA法测定TPO水平。

主要发现

  • 诊断14例(13%)mBSS,与GP1BA和GP1BB杂合变异相关。
  • 6个无关先证者携带GP1BA c.58T>G(p.Cys20Gly)杂合变异,共享染色体17上2.0 Mb区域,证实为奠基者变异。
  • mBSS患者与野生型家庭成员间TPO水平无差异(P > .05)。

关键数值与推荐

  • mBSS诊断基于GP1BA或GP1BB杂合变异。
  • 奠基者变异判定标准:先证者无亲缘关系且变异周围区域共享。
  • TPO水平比较P > .05视为无差异。

临床怎么用

  • 对疑似遗传性血小板减少症患者应筛查GP1BA c.58T>G变异,尤其在丹麦人群。
  • mBSS表现为轻度无症状性大血小板减少症,需与经典BSS鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The classic Bernard-Soulier syndrome (BSS) is a rare inherited thrombocytopenia (IT) associated with severe thrombocytopenia, giant platelets, and bleeding tendency caused by homozygous or compound heterozygous variants in GP1BA, GP1BB, or GP9. Monoallelic BSS (mBSS) associated with mild asymptomatic macrothrombocytopenia caused by heterozygous variants in GP1BA or GP1BB may be a frequent cause of mild IT. OBJECTIVE: We aimed to examine the frequency of mBSS in a consecutive cohort of patients with IT and to characterize the geno- and phenotype of mBSS probands and their family members. Additionally, we set out to examine if thrombopoietin (TPO) levels differ in mBSS patients. PATIENTS/METHODS: We screened 106 patients suspected of IT using whole exome- or whole genome sequencing and performed co-segregation analyses of mBSS families. All probands and family members were phenotypically characterized. Founder mutation analysis was carried out by certifying that the probands were unrelated and the region around the variant was shared by all patients. TPO was measured by solid phase sandwich ELISA. RESULTS: We diagnosed 14 patients (13%) with mBSS associated with heterozygous variants in GP1BA and GP1BB. Six unrelated probands carried a heterozygous variant in GP1BA (c.58T>G, p.Cys20Gly) and shared a 2.0 Mb region on chromosome 17, confirming that it is a founder variant. No discrepancy of TPO levels between mBSS patients and wild-type family members (P > .05) were identified. CONCLUSION: We conclude that the most frequent form of IT in Denmark is mBSS caused by the Copenhagen founder variant.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Leinøe E, Brøns N, Rasmussen AØ, et al. The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark. J Thromb Haemost. 2021. PMID: 34333846. doi:10.1111/jth.15479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。